4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects.
暂无分享,去创建一个
P. Fischer | G. Kontopidis | M. Hajdúch | M. Strnad | W. F. De Azevedo | J. Srovnal | V. Kryštof | Petr Cankař | Iveta Fryšová | J. Slouka, | P. Džubák | M. Orság | M. Paprskářová | J. Rolcik | Aleš Látr | J. Slouka | M. Hajdůch | M. Paprskářová | W. F. D. de Azevedo